LENZ Therapeutics (LENZ) Accumulated Depreciation & Amortization (2020 - 2025)

LENZ Therapeutics (LENZ) has 6 years of Accumulated Depreciation & Amortization data on file, last reported at $287000.0 in Q4 2025.

• Accumulated Depreciation & Amortization for Q4 2025 came in at $287000.0, up 394.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $287000.0 (up 394.83% YoY), and the FY2025 annual result was $287000.0, up 394.83% from the prior year.
• Accumulated Depreciation & Amortization climbed to $287000.0 in Q4 2025 per LENZ's latest filing, from $58000.0 in the prior quarter.
• Over five years, Accumulated Depreciation & Amortization peaked at $3.9 million in Q1 2023 and troughed at $15000.0 in Q4 2023.
• A 5-year average of $1.5 million and a median of $855000.0 in 2021 frame the typical range for Accumulated Depreciation & Amortization.
• The sharpest annual moves came in 2021 and 2023: Accumulated Depreciation & Amortization jumped 606.61% in 2021, then slumped 99.53% in 2023.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $855000.0 in 2021, then jumped by 275.09% to $3.2 million in 2022, then tumbled by 99.53% to $15000.0 in 2023, then soared by 286.67% to $58000.0 in 2024, then soared by 394.83% to $287000.0 in 2025.
• Business Quant data shows LENZ's Accumulated Depreciation & Amortization at $287000.0 in Q4 2025, $58000.0 in Q4 2024, and $15000.0 in Q4 2023.